Sowilo India Pharmaceuticals Private Limited, a active private limited company, was established on 17 October 2018 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51909DL2018PTC340658. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.15 M.
Employing 30 professional, Its leadership includes Savita Tiwari (Director), Poonam Srivastava (Director), Tripti Shukla (Director). It holds ₹6.07 M open charges and no settled loans. Its latest AGM occurred on 29 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No-27/110/2 Gali No-6,Block-E West Karawal Nagar, Delhi, Delhi, 110094.
U51909DL2018PTC340658
340658
17 October 2018
₹0.20 M
₹0.15 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Sowilo India Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Savita Tiwari | Director | 17 Oct 2018 | Current |
| Poonam Srivastava | Director | 17 Oct 2018 | Current |
| Tripti Shukla | Director | 11 Jun 2021 | Current |
| Jatin Trivedi | Director | 13 Aug 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sowilo India Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.05% increase. The company also saw a substantial improvement in profitability, with a 138.69% increase in profit. The company's net worth Soared by an impressive increase of 87.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sowilo India Pharmaceuticals had a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,068,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2024 | Hdfc Bank Limited | ₹2.19 M | Open |
| 06 Jul 2023 | Hdfc Bank Limited | ₹2.50 M | Open |
| 30 Apr 2021 | Hdfc Bank Limited | ₹1.38 M | Open |
Explore comprehensive loan charge details -
Sowilo India Pharmaceuticals has a workforce of 30 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sowilo India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sowilo India Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.19 M with Charge ID 101053533 was registered on 31 Dec 2024. was documented.
Progress on Sowilo India Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records. was documented.
The activity Sowilo India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 2.50 M with Charge ID 100751743 was registered on 06 Jul 2023. was recorded as a recent event.
The activity Tripti Shukla was appointed as a Director was appointed as a Director on 11 Jun 2021 & has been associated with this company since 4 years 6 months . was completed.
A charge with Hdfc Bank Limited amounted to Rs. 1.38 M with Charge ID 100455491 was registered on 30 Apr 2021. was recorded as a recent event.
The CIN of Sowilo India Pharmaceuticals Private Limited is U51909DL2018PTC340658.
Sowilo India Pharmaceuticals Private Limited is headquartered at H.No-27/110/2 Gali No-6,Block-E West Karawal Nagar, Delhi, Delhi, 110094.
Sowilo India Pharmaceuticals Private Limited was incorporated on 17 October 2018.
The current directors of Sowilo India Pharmaceuticals Private Limited are
The primary industry of Sowilo India Pharmaceuticals Private Limited is Manufacturing.
Sowilo India Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sowilo India Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.15 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX